Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E
- PMID: 2063194
- DOI: 10.1126/science.2063194
Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E
Abstract
Human apolipoprotein E, a blood plasma protein, mediates the transport and uptake of cholesterol and lipid by way of its high affinity interaction with different cellular receptors, including the low-density lipoprotein (LDL) receptor. The three-dimensional structure of the LDL receptor-binding domain of apoE has been determined at 2.5 angstrom resolution by x-ray crystallography. The protein forms an unusually elongated (65 angstroms) four-helix bundle, with the helices apparently stabilized by a tightly packed hydrophobic core that includes leucine zipper-type interactions and by numerous salt bridges on the mostly charged surface. Basic amino acids important for LDL receptor binding are clustered into a surface patch on one long helix. This structure provides the basis for understanding the behavior of naturally occurring mutants that can lead to atherosclerosis.
Similar articles
-
Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein.Structure. 1994 Aug 15;2(8):713-8. doi: 10.1016/s0969-2126(00)00072-1. Structure. 1994. PMID: 7994571
-
The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts.Biochemistry. 2000 Jan 11;39(1):213-20. doi: 10.1021/bi991209w. Biochemistry. 2000. PMID: 10625496
-
Conformationally specific enhancement of receptor-mediated LDL binding and internalization by peptide models of a conserved anionic N-terminal domain of human apolipoprotein E.Biochemistry. 1996 Nov 5;35(44):13975-84. doi: 10.1021/bi960006u. Biochemistry. 1996. PMID: 8909295
-
Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.Clin Exp Nephrol. 2014 Apr;18(2):220-4. doi: 10.1007/s10157-013-0918-1. Epub 2014 Feb 26. Clin Exp Nephrol. 2014. PMID: 24570178 Review.
-
Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.Pathology. 2019 Feb;51(2):165-176. doi: 10.1016/j.pathol.2018.11.002. Epub 2018 Dec 28. Pathology. 2019. PMID: 30598326 Review.
Cited by
-
ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies.Mol Neurodegener. 2022 Nov 8;17(1):72. doi: 10.1186/s13024-022-00574-4. Mol Neurodegener. 2022. PMID: 36348357 Free PMC article. Review.
-
Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease.J Mol Neurosci. 2004;23(3):189-204. doi: 10.1385/JMN:23:3:189. J Mol Neurosci. 2004. PMID: 15181247 Review.
-
The Role of ApoE in HCV Infection and Comorbidity.Int J Mol Sci. 2019 Apr 25;20(8):2037. doi: 10.3390/ijms20082037. Int J Mol Sci. 2019. PMID: 31027190 Free PMC article. Review.
-
Charged Residues in the C-Terminal Domain of Apolipoprotein A-I Modulate Oligomerization.Biochemistry. 2018 Apr 17;57(15):2200-2210. doi: 10.1021/acs.biochem.7b01052. Epub 2018 Apr 3. Biochemistry. 2018. PMID: 29578333 Free PMC article.
-
Impact of self-association on function of apolipoprotein A-I.J Biol Chem. 2011 Oct 14;286(41):35610-35623. doi: 10.1074/jbc.M111.262485. Epub 2011 Aug 11. J Biol Chem. 2011. PMID: 21835924 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous